Veglianese P, Lo Coco D, Bao Cutrona M, Magnoni R, Pennacchini D, Pozzi B, Gowing G, Julien J P, Tortarolo M, Bendotti C
Lab. Molecular Neurobiology, Dept. Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy.
Mol Cell Neurosci. 2006 Feb;31(2):218-31. doi: 10.1016/j.mcn.2005.09.009. Epub 2005 Oct 10.
Phosphorylated p38 mitogen-activated protein kinase (p38MAPK), but not activated c-jun-N-terminal kinase (JNK), increases in the motor neurons of transgenic mice overexpressing ALS-linked SOD1 mutants at different stages of the disease. This effect is associated with a selective increase of phosphorylated MKK3-6, MKK4 and ASK1 and a concomitant upregulation of the TNFalpha receptors (TNFR1 and TNFR2), but not IL1beta and Fas receptors. Activation of both p38 MAPK and JNK occurs in the activated microglial cells of SOD1 mutant mice at the advanced stage of the disease; however, this effect is not accompanied by the concomitant activation of the upstream kinases ASK1 and MKK3,4,6, while both the TNFRs are overexpressed in these cells. No changes of the upstream p38MAPK cascade kinases or TNFRs occur in reactive astrocytes. These findings highlight the activation of a selective intracellular signaling pathway in the motor neurons of SOD1 mutant mice, which is likely implicated in their death.
在疾病不同阶段过表达与肌萎缩侧索硬化症(ALS)相关的超氧化物歧化酶1(SOD1)突变体的转基因小鼠的运动神经元中,磷酸化的p38丝裂原活化蛋白激酶(p38MAPK)增加,而活化的c-jun氨基末端激酶(JNK)未增加。这种效应与磷酸化的MKK3-6、MKK4和ASK1的选择性增加以及肿瘤坏死因子α受体(TNFR1和TNFR2)的伴随上调有关,但与白细胞介素1β受体和Fas受体无关。在疾病晚期,p38 MAPK和JNK均在SOD1突变小鼠的活化小胶质细胞中被激活;然而,这种效应并未伴随着上游激酶ASK1和MKK3、4、6的同时激活,而这两种肿瘤坏死因子受体在这些细胞中均过表达。反应性星形胶质细胞中上游p38MAPK级联激酶或肿瘤坏死因子受体无变化。这些发现突出了SOD1突变小鼠运动神经元中选择性细胞内信号通路的激活,这可能与其死亡有关。